Taiwanese Version of the M. D. Anderson Symptom Inventory

Symptom Assessment in Cancer Patients

Chia-Chin Lin, Ai Ping Chang, Charles S. Cleeland, Tito R. Mendoza, Xin Shelley Wang

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

The purpose of this study was to validate the Taiwanese version of the M. D. Anderson Symptom Inventory (MDASI-T) in a sample of 556 Taiwanese patients with multiple diagnoses of cancer. The internal consistency Cronbach alpha was 0.89 for symptom severity items and 0.94 for interference items. The test-retest reliability was 0.97 for the severity composite score and 0.96 for the interference composite score over a 3-day interval in a sample of 12 patients. Construct validity was established by factor analysis, which revealed a two-factor structure. Concurrent validity was examined by correlating the MADSI-T scores and scores of the Medical Outcome Study 36-Item Short-Form Health Survey. Known-group validity was established by comparing MDASI-T scores between patients having low functional status and those having high functional status (Karnofsky Performance Status scores ≤50 or >50, respectively) and between inpatients and outpatients. The MDASI-T's sensitivity (its ability to detect small differences in reporting variations) was examined by comparing the MDASI-T composite symptom scores and composite interference scores before, during, and one week after treatment in a sample of 20 breast cancer patients receiving chemotherapy. The MDASI-T is a reliable, valid, and sensitive instrument for measuring the severity and interference with daily life of cancer-related symptoms among Taiwanese cancer patients.

Original languageEnglish
Pages (from-to)180-188
Number of pages9
JournalJournal of Pain and Symptom Management
Volume33
Issue number2
DOIs
Publication statusPublished - Feb 2007

Fingerprint

Symptom Assessment
Equipment and Supplies
Neoplasms
Karnofsky Performance Status
Health Surveys
Reproducibility of Results
Statistical Factor Analysis
Inpatients
Outpatients
Outcome Assessment (Health Care)
Breast Neoplasms
Drug Therapy

Keywords

  • assessment tool
  • reliability
  • sensitivity
  • symptoms
  • Taiwan
  • validation
  • validity

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Neurology
  • Nursing(all)

Cite this

Taiwanese Version of the M. D. Anderson Symptom Inventory : Symptom Assessment in Cancer Patients. / Lin, Chia-Chin; Chang, Ai Ping; Cleeland, Charles S.; Mendoza, Tito R.; Wang, Xin Shelley.

In: Journal of Pain and Symptom Management, Vol. 33, No. 2, 02.2007, p. 180-188.

Research output: Contribution to journalArticle

Lin, Chia-Chin ; Chang, Ai Ping ; Cleeland, Charles S. ; Mendoza, Tito R. ; Wang, Xin Shelley. / Taiwanese Version of the M. D. Anderson Symptom Inventory : Symptom Assessment in Cancer Patients. In: Journal of Pain and Symptom Management. 2007 ; Vol. 33, No. 2. pp. 180-188.
@article{d7ecaec4f62844d78d2b29ae56d0e7f6,
title = "Taiwanese Version of the M. D. Anderson Symptom Inventory: Symptom Assessment in Cancer Patients",
abstract = "The purpose of this study was to validate the Taiwanese version of the M. D. Anderson Symptom Inventory (MDASI-T) in a sample of 556 Taiwanese patients with multiple diagnoses of cancer. The internal consistency Cronbach alpha was 0.89 for symptom severity items and 0.94 for interference items. The test-retest reliability was 0.97 for the severity composite score and 0.96 for the interference composite score over a 3-day interval in a sample of 12 patients. Construct validity was established by factor analysis, which revealed a two-factor structure. Concurrent validity was examined by correlating the MADSI-T scores and scores of the Medical Outcome Study 36-Item Short-Form Health Survey. Known-group validity was established by comparing MDASI-T scores between patients having low functional status and those having high functional status (Karnofsky Performance Status scores ≤50 or >50, respectively) and between inpatients and outpatients. The MDASI-T's sensitivity (its ability to detect small differences in reporting variations) was examined by comparing the MDASI-T composite symptom scores and composite interference scores before, during, and one week after treatment in a sample of 20 breast cancer patients receiving chemotherapy. The MDASI-T is a reliable, valid, and sensitive instrument for measuring the severity and interference with daily life of cancer-related symptoms among Taiwanese cancer patients.",
keywords = "assessment tool, reliability, sensitivity, symptoms, Taiwan, validation, validity",
author = "Chia-Chin Lin and Chang, {Ai Ping} and Cleeland, {Charles S.} and Mendoza, {Tito R.} and Wang, {Xin Shelley}",
year = "2007",
month = "2",
doi = "10.1016/j.jpainsymman.2006.07.018",
language = "English",
volume = "33",
pages = "180--188",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Taiwanese Version of the M. D. Anderson Symptom Inventory

T2 - Symptom Assessment in Cancer Patients

AU - Lin, Chia-Chin

AU - Chang, Ai Ping

AU - Cleeland, Charles S.

AU - Mendoza, Tito R.

AU - Wang, Xin Shelley

PY - 2007/2

Y1 - 2007/2

N2 - The purpose of this study was to validate the Taiwanese version of the M. D. Anderson Symptom Inventory (MDASI-T) in a sample of 556 Taiwanese patients with multiple diagnoses of cancer. The internal consistency Cronbach alpha was 0.89 for symptom severity items and 0.94 for interference items. The test-retest reliability was 0.97 for the severity composite score and 0.96 for the interference composite score over a 3-day interval in a sample of 12 patients. Construct validity was established by factor analysis, which revealed a two-factor structure. Concurrent validity was examined by correlating the MADSI-T scores and scores of the Medical Outcome Study 36-Item Short-Form Health Survey. Known-group validity was established by comparing MDASI-T scores between patients having low functional status and those having high functional status (Karnofsky Performance Status scores ≤50 or >50, respectively) and between inpatients and outpatients. The MDASI-T's sensitivity (its ability to detect small differences in reporting variations) was examined by comparing the MDASI-T composite symptom scores and composite interference scores before, during, and one week after treatment in a sample of 20 breast cancer patients receiving chemotherapy. The MDASI-T is a reliable, valid, and sensitive instrument for measuring the severity and interference with daily life of cancer-related symptoms among Taiwanese cancer patients.

AB - The purpose of this study was to validate the Taiwanese version of the M. D. Anderson Symptom Inventory (MDASI-T) in a sample of 556 Taiwanese patients with multiple diagnoses of cancer. The internal consistency Cronbach alpha was 0.89 for symptom severity items and 0.94 for interference items. The test-retest reliability was 0.97 for the severity composite score and 0.96 for the interference composite score over a 3-day interval in a sample of 12 patients. Construct validity was established by factor analysis, which revealed a two-factor structure. Concurrent validity was examined by correlating the MADSI-T scores and scores of the Medical Outcome Study 36-Item Short-Form Health Survey. Known-group validity was established by comparing MDASI-T scores between patients having low functional status and those having high functional status (Karnofsky Performance Status scores ≤50 or >50, respectively) and between inpatients and outpatients. The MDASI-T's sensitivity (its ability to detect small differences in reporting variations) was examined by comparing the MDASI-T composite symptom scores and composite interference scores before, during, and one week after treatment in a sample of 20 breast cancer patients receiving chemotherapy. The MDASI-T is a reliable, valid, and sensitive instrument for measuring the severity and interference with daily life of cancer-related symptoms among Taiwanese cancer patients.

KW - assessment tool

KW - reliability

KW - sensitivity

KW - symptoms

KW - Taiwan

KW - validation

KW - validity

UR - http://www.scopus.com/inward/record.url?scp=33846828474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846828474&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2006.07.018

DO - 10.1016/j.jpainsymman.2006.07.018

M3 - Article

VL - 33

SP - 180

EP - 188

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 2

ER -